Reference ranges provide a comparison framework for deciding whether a biological measurement is consistent with expected health findings. Diagnostic markers add targeted evidence linked to a disease process, physiological change, or biological condition. Interpreting either type of result requires relating the observed finding to established standards, which helps distinguish clinically meaningful abnormalities from measurements that fall within expected variation.
Each discipline examines a different biological level. Molecular biology can support analysis of genetic or other molecular features, microbiology addresses infectious causes, immunology examines immune-related evidence, and pathology evaluates disease-associated changes in tissues. Combining these perspectives broadens diagnostic assessment and helps connect laboratory findings with infections, genetic conditions, cancer, or organ dysfunction.
Biomarker discovery expands the measurable signals available for identifying disease or assessing health, while genomics adds information from genetic patterns. Together, these advances can increase diagnostic precision and support more individualized interpretation of biological findings. Their value extends across detection, prognosis, treatment selection, and monitoring, rather than being limited to confirming an established diagnosis.
A diagnostic workflow begins with an appropriate biological sample, such as blood, urine, or tissue, or with imaging that captures a physiological change. The material or image is then analyzed for relevant measurements or markers. Findings are compared with reference ranges or diagnostic standards and interpreted to support a clinical decision, such as screening, diagnosis, or monitoring.
The purpose determines how findings are interpreted and applied. Screening seeks evidence relevant to health assessment, diagnosis investigates whether disease is present, prognosis helps assess the expected course, and monitoring tracks changes over time. The same general diagnostic resources can therefore support different stages of care, including treatment selection and evaluation of ongoing patient status.
Point-of-care testing brings diagnostic measurements closer to the setting where medical decisions are made. Its importance lies in improving the speed and accessibility of results while preserving the goal of guiding patient care. As this approach develops, it complements laboratory-based testing and imaging by making selected biological information available in more immediate or distributed clinical contexts.
Clinical diagnostics can provide evidence relevant to infections, genetic conditions, cancer, and organ dysfunction. The biological basis of each investigation differs, so testing may draw on molecular biology, microbiology, immunology, pathology, laboratory measurements, or imaging. This range illustrates how biology connects measurable molecular, cellular, tissue, and physiological changes with decisions about patient care.